文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

T cells in cancer: mechanistic insights and therapeutic advances.

作者信息

Pu Jingjing, Liu Ting, Zhou Yi, Chen Mengping, Fu Xuehang, Wan Yike, Wang Junying, Chen Binzhen, Sharma Amit, Lukacs-Kornek Veronika, Schmidt-Wolf Ingo G H, Hou Jian

机构信息

Department of Hematology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, 200127, China.

Department of Geriatrics, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, 200127, China.

出版信息

Biomark Res. 2025 Jul 15;13(1):97. doi: 10.1186/s40364-025-00807-w.

DOI:10.1186/s40364-025-00807-w
PMID:40660400
Abstract
摘要

相似文献

[1]
T cells in cancer: mechanistic insights and therapeutic advances.

Biomark Res. 2025-7-15

[2]
A bibliometric analysis of challenges and advancements in the integrated application of nanoparticles and chimeric antigen receptor T cell therapy.

Hum Vaccin Immunother. 2025-12

[3]
T cell subsets in cervical cancer tumor microenvironment: advances and therapeutic opportunities.

Front Immunol. 2025-6-5

[4]
Immuno-Oncology at the Crossroads: Confronting Challenges in the Quest for Effective Cancer Therapies.

Int J Mol Sci. 2025-6-26

[5]
CAR-Based Cell Therapy in Head and Neck Cancer: A Comprehensive Review on Clinical Applicability.

Cancers (Basel). 2025-7-1

[6]
LAG3+ CD8+ T cell Subset Drives HR+/HER2- Breast Cancer Reduction in Bispecific Antibody Armed Activated T Cell Therapy.

bioRxiv. 2025-5-10

[7]
Innovative pan-tumor target strategy for CAR-T therapy: cancer-specific exons as novel targets for pediatric solid and brain tumors.

J Transl Med. 2024-11-12

[8]
Combretastatin A4-Based Albumin Nanoparticles Remodeling the Tumor Immune Microenvironment to Enhance T Cell Immunotherapy in Colon Cancer.

ACS Nano. 2025-7-8

[9]
Advances and challenges in cancer immunotherapy: Strategies for personalized treatment.

Semin Oncol. 2025-4-29

[10]
Advances in cancer immunotherapy: The role of super NK and super CAR-T cells.

Int Immunopharmacol. 2025-8-28

本文引用的文献

[1]
The clinical landscape of CAR-engineered unconventional T cells.

Trends Cancer. 2025-6

[2]
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China.

Lancet. 2025-3-8

[3]
Biological functions and therapeutic applications of human mucosal-associated invariant T cells.

J Biomed Sci. 2025-3-1

[4]
BCMA-targeted therapies for multiple myeloma: latest updates from 2024 ASH annual meeting.

J Hematol Oncol. 2025-3-1

[5]
Outcome correlates of approved CD19-targeted CAR T cells for large B cell lymphoma.

Nat Rev Clin Oncol. 2025-4

[6]
Art of TIL immunotherapy: SITC's perspective on demystifying a complex treatment.

J Immunother Cancer. 2025-1-20

[7]
Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma.

J Clin Oncol. 2025-5-20

[8]
TNF/TNFR Superfamily Members in Costimulation of T Cell Responses-Revisited.

Annu Rev Immunol. 2025-4

[9]
PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial.

Nat Commun. 2024-12-30

[10]
GATA3: Orchestrating cellular fate through differentiation and proliferation.

Biochim Biophys Acta Mol Cell Res. 2025-2

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索